Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Henry M Sobell

Henry M Sobell

University of Rochester USA

Wladek Minor

Wladek Minor

University of Virginia USA

Timothy A Cross

Timothy A Cross

Florida State University & National High Magnetic Field Lab USA

Robert Craigie

Robert Craigie

NIH USA

Petra Fromme

Petra Fromme

Arizona State University USA

Yuri L. Lyubchenko

Yuri L. Lyubchenko

University of Nebraska USA

Charles W. Carter, Jr

Charles W. Carter, Jr

University of North Carolina USA

Nebojsa Janjic

Nebojsa Janjic

SomaLogic USA

Euro Metabolomics 2018

About Conference


13th International Conference on Metabolomics and Systems Biology scheduled to be held during June 11-12, 2018 in UK, London. This is a wonderful opportunity for the participants from the Universities and Organizations to network with the eminent Scientists. The theme of the conference is “Metabolomics:  An emerging tool for understating cellular metabolites”.

Euro Metabolomics 2018 will be a platform to investigate on recent research and advancements that can be useful to the researchers. Metabolomics is a rapidly emerging field to identify and quantify cellular metabolites of a biological system at a particular point of time by using sophisticated analytical techniques. Most recent innovations covered in the conference are Metabolomic Modelling and Drug Design, Precision Medicine, NMR, LC-MS, GC-MS, Mass Spectrometry, UPLC and Ion mobility spectrometry analytical methods, Targeted Metabolomics, Biomarker Metabolomics, Cancer MetabolomicsMetabolomic Profiling, Metabolomic Fingerprinting, Lipidomics, Data analysis using Systems Biology approach.

Sessions/Tracks

Track 1: Metabolomics
 
It is the large-scale study of small molecules, commonly known as metabolites, within cells, bio fluids, tissues or organisms. Collectively, these small molecules and their interactions within a biological system are known as the metabolome. Metabolomics represents the molecular phenotype. Four conceptual approaches in metabolomics - target analysis, metabolite profiling, metabolomics, and metabolic fingerprinting. Target analysis includes the determination and quantification of a small set of known metabolites (targets) using one of the specific analytical technique of best performance. On the other hand Metabolite profiling aims at the analysis of a larger set of compounds, both known and unknown with respect to their chemical nature. This approach has been applied for many different biological systems using GC-MS, including plants, microbes, urine, and plasma samples. Metabolomics employs complementary analytical methodologies, for example, LC-MS/MS, GC-MS, and/or NMR, in order to determine and quantify as many metabolites as possible, either identified or unknown compounds. The last approach is metabolic finger-printing.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
Cancer is basically a metabolic disease. Cancer cells are different from normal cells as they show a distinct metabolic phenotype, they consume more glucose than normal cells. This glycolytic phenotype is known as the Warburg effect. The re-discovery of cancer as a metabolic disorder happened in the past ten years, this is due to the increased accessibility of metabolomics, identification of cancer metabolite biomarkers and the discovery of oncometabolites. Metabolomics application in the field of cancer research has led to the progress of metabolism in development of cancer. Cancer is a metabolic disease which changes the digestion system of the cell and encompassing milieu. Metabolomics in field of pharmaceuticals is turning into an inexorably mainstream instrument for life sciences as it is generally quick and also precise procedure this can be connected with either a specific centre or in a worldwide way to uncover new learning about organic frameworks.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA; 13th National Cancer Research Institute Cancer Conference, November 5-8, 2017 Liverpool, UK; 33rd German Cancer Congress, February 21-24 2018s Berlin, Germany; Clinical Oncological Society of Australia 44th Annual Scientific Meeting, November 14-16, 2017 Sydney, Australia.
 
 
A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development, and, optimally, to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA;11th Biomarker Summit, March 27-28, 2018 in California, USA; 13th Annual Biomarkers Congress, February 15-16 2018, Manchester, UK.
 
 
Synthetic Biology aims to create novel biological functions and systems not found in nature by combining biology with engineering. The workflow of the development of novel cell factories with synthetic biology is ideally linear which will be attainable with the quantitative engineering approach, high-quality predictive models, and libraries of well-characterized parts. Different types of metabolic models, mathematical representations of metabolism and its components, enzymes and metabolites, are useful in particular phases of the synthetic biology workflow.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA; Keystone Symposia Conference on Natural Products and Synthetic Biology, January 22-24, 2018, California, USA.
 
 
The new field of precision medicine is revolutionizing current medical practice and reshaping future medicine. Precision medicine aspires to put the patient as the central driver of healthcare by broadening biological knowledge and acknowledging the greater diversity of individuals. It is well established that complex gene–environment interactions shape normal physiological and disease processes at both the individual and population scale. Predicting normal and pathological states in patients requires dynamic and systematic understanding of these interactions. Systems medicine is a new concept based on holistic approaches for disease diagnosis and monitoring.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA;World Precision Medicine Congress, May 16-18, 20-18 London, UK; UF Precision Medicine Conference 2018.
 
 
Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. A consequence of disease leads to metabolic changes. These changes are the cause of disease advancement. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs. 
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, USA; Drug Discovery and Therapy World Congress, July 09-12, 2018, Boston, USA;Cambridge Healthtech Institute's 13th Annual Drug Discovery Chemistry, April 2-6, 2018 California, USA.
 
Track 7: Edibilomics
 
Nutritional metabolomics is rapidly maturing to use small molecule chemical profiling to support integration of diet and nutrition in complex bio systems research. These developments are critical to facilitate transition of nutritional sciences from population-based to individual-based criteria for nutritional research, assessment and management. Utilizing metabolomics, scientists can quantitatively dissect non-hereditary variables that are included in post genomic and posttranscriptional change. Foodomics has been recently defined as a new discipline that studies food and nutrition domains through the application of advanced omics technologies in which MS techniques are considered indispensable. Applications of Foodomics include the genomic, transcriptomic, proteomic, and/or metabolomic study of foods for compound profiling, authenticity, and/or biomarker-detection related to food quality or safety; the development of new transgenic foods, food contaminants, and whole toxicity studies; new investigations on food bioactivity, food effects on human health. 
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA; International Conference on Foodomics, January 10-11, 2018; Nutrition 2018-American Society of Nutrition, June 9-12, 2018, Boston, USA.
 
Track 8: Lipidomics
 
Lipids are the important participant in control and regulation of cellular function. The diversity of chemical structure of these lipids is a major challenge for managing high volumes of complex data. The need for bioinformatics is to manage and integrate the experimental data in various aspects, such as, for lipid classification, ontologies, database design, analysis, and visual display. They play diverse roles in human physiology. Lipidomics is a growing field with numerous applications. For analysing different cell types ESI mass spectroscopy is used. Identification of lipid composition and quantification of cellular lipids gives us details about the lipid related pathway which also helps in identification of metabolic pathways and the effected enzymes.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
Metabolomics is the analysis of low atomic mass metabolites inside a cell, tissue, or bio fluid. The sub control of environmental metabolomics is the application of metabolomic strategies to investigate the connections of life forms with their surroundings. Drug metabolism system is the procedure by which the body separates and changes over pharmaceutical into dynamic concoction substances. Toxicology is a branch of Medical Science that arrangements with the impacts of synthetic compound utilized as a part of the conclusion, treatment, or counteractive action of ailment or other unusual condition on the body. Plant Metabolomics is to characterise at sub atomic level of the total metabolite pool (metabolome) of plants under particular conditions. Metabolomics is used for a better understanding of the correlation between genes and the biochemical composition of a plant tissue in response to its environment can be obtained, and this information can be further used to assess gene function. 
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
The transcriptomics refers to study of transcriptome. The transcriptome is dynamic, as the levels of RNA transcripts vary during response to certain conditions in the cell or in different developmental stages of the cell. RNA-Seq or Transcriptome sequencing is a next-generation sequencing (NGS)-based approach for RNA profiling and analysis. Proteomics refers to study of large-scale proteomes. Proteome is a set of proteins produced in an organism or biological environment. One of the Systems Biology’s important objectives is to understand the regulation of cell behavior. And important approaches involve are Measure of transcriptomic profiles through microarrays, RNA-seq etc. and Measure of proteomic profiles through techniques such as gel electrophoresis and mass spectrometry.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
Track 11: Systems Biology 
 
Systems biology is the mathematical and computational modelling of biological components, which may be molecules, cells, organisms or entire species. Living systems are complex and dynamic, and their activities are difficult to predict from the properties of individual parts. For studying all these, quantitative measurements of the behaviour of groups of interacting components are used and also technologies such as genomics, bioinformatics, proteomics, mathematical and computational models are used for describing and predicting dynamical behaviour.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
Computational Biology is a rapidly emerging field, at the interface of computer science, arithmetic, physics and biology. It endeavours to study, analyse and understand complex biological systems by taking a corresponding integrated systems view using computational methodologies. The recent advances in sophisticated computational methodologies are high throughput techniques and computational power. The striking developments in biology and computer science are playing a key role in the fast progression of the evolving field. Computational systems biology provides a point of merging for genomics, proteomics, metabolomics and computational modelling.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
Metabolomics is the quantitative and qualitative study of small molecules. It is said to be an important technique in systems biology. Metabolites include a diverse group of low molecular weight structures such as lipids, nucleic acids, vitamins, amino acids, peptides, thiols, organic acids and carbohydrates, which makes analysis a big task. The recent development of analytical platforms, such as GC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy, enables separation, detection, characterization and quantification of these metabolites and other related metabolic pathways. Because of the complexity of the metabolome and diverse properties of the metabolites, single analytical platform cannot be used for detecting all metabolites in a sample. The combined use of modern instrumental analytical approaches has led to the ideal outcomes, and is important for increasing the coverage of metabolites which cannot be achieved by single-analysis techniques. Integrated platforms are frequently being used for providing sensitive and reliable detection of thousands of metabolites in a bio fluid sample. Continuous development of these analytical platforms will accelerate extensive use and integration of metabolomics into systems biology.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
The latest addition of “omics” disciplines is Metabolomics and it has shown rapid growth in the application to human health research because of major advancements in measurement and analysis techniques. Metabolomics has unique advantages in systems biology and biomarker discovery. The next generation of analysis techniques promises even richer and more complete analysis capabilities that will enable earlier clinical diagnosis, drug refinement, and personalized medicine. The advancements in methodologies and statistical analysis that are enhancing and improving the performance of metabolomics is presented along with highlights of some recent successful applications.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
Metabolic syndrome is a set of conditions such as increase in blood pressure, high blood sugar, excess body fat, and abnormal cholesterol or triglyceride levels all these symptoms occur together which in turn increases the risk of heart disease, diabetes and stroke. More than one of these conditions leads to increased risk. Metabolomics provides molecular information that has potential applications in understanding pathogenesis. It has been playing an important role in unravelling the pathophysiology and identifying early biomarkers of specific physiological responses of complex human diseases in particular metabolic syndrome.
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
Metabolomics, alternately metabonomics, a growing field of biochemical exploration, is a reciprocal procedure to genomics, transcriptomics, and proteomics. Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomic research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex examples, for example, blood, pee, or tissue removes with practically zero preparing. Thermo Fisher, AB SCIEX, and Bruker likewise offer instruments for imaging MS, additionally called MALDI imaging. To meet difficulties of searchability and information reconciliation, the metabolomics group has a few activities to build up information vaults. Cases are Metabolights in the United Kingdom, bolstered by the European COSMOS (COordination of Standards in MetabOlomicS) consortium that is creating metabolomics information norms, and Metabolomics Workbench, which means to be the database for NIH-subsidized metabolomics ventures. 
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.
 
 
They are a vital direct source of confirmation in pharmaceutical and a device regularly utilized as a part of practice to craft data and create a more extended quest for proof. A decent case report will be vibrant about the significance of the perception being accounted for. In addition to the “evidence of what happened”, single or multiple cases are an important origin for further and more advanced research on diagnosis, treatment adequacy, reasons and results of ailment. Case reports might be first to give signs in differentiating another ailment or unfriendly wellbeing impact from a presentation. 
 
 
9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-14, 2017, Paris, France; 9th International Conference on Bioinformatics November 13-14, 2017 Paris, France; 3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy; 3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 4th Glycobiology World Congress, September 17-19, 2018 Rome, Italy; MetaboMeeting 11-13 December 2017, University of Birmingham, UK; Global Summit on Metabolomics, July 16-17, 2018, Miami, USA; 14th International Conference of the Metabolomics Society, June 25-28, 2018, Seattle, Washington, USA; Intelligent Systems for Molecular Biology - ISMB 2018, Chicago, USA; From Functional Genomics to Systems Biology, November 10-13, 2018, Heidelberg, Germany; International Conference on Systems Biology, May 07-08, 2018, Dubai, UAE; BioSB 2018 conference: Bioinformatics & Systems Biology conference May 15-16, 2018, Lunteren, Netherlands; Bioinformatics and Computational Biology (BICOB), March 19-21, 2018, Las Vegas, Nevada, USA.

 

Market Analysis

Scope and Importance:
 
Metabolomics is the quantitative and qualitative study of small molecules. It is said to be an important technique in systems biology. The purposes of metabolomics is accurate detection of disease, such as inflammation, necrosis, estimation of toxicity in newly designed drugs, Alzheimer’s, drug testing and interpreting biochemical pathways.  Greater than 95% of clinical diagnostic assays tests are for small molecules. From pre-existing metabolites 50% of the drugs are derived from known small molecule drugs.                      
 
Metabolomics Market Analysis:
 
The global metabolomics market is expected to grow at a CAGR of 26% from 2016 to 2021 to reach USD 3.53 Billion by 2021.The metabolomics market has significant growth mainly due to the increasing necessity for accurate diagnosis of diseases, development of innovative technologies, and increasing demand for precision medicine.                      
 
Europe is the second largest Market in the world with a share of ~38% of the global market. The presence of a large number of analytical equipment manufacturers has contributed significantly to the European metabolomics market. The APAC market is expected to grow at a CAGR of 23% during the forecast period.
 
Why London?
 
London is the most populous city in the United Kingdom. London is a leading global city, with strengths in the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism, and transport all contributing to its prominence. It is one of the world's leading financial centres and has the fifth-or sixth-largest metropolitan area GDP in the world depending on measurement. London is a world cultural capital. It is the world's most-visited city as measured by international arrivals and has the world's largest city airport system measured by passenger traffic. London is the world's leading investment destination, hosting more international retailers and ultra-high net-worth individuals than any other city. London's 43 universities form the largest concentration of higher education institutes in Europe, and a 2014 report placed it first in the world university rankings. In 2012, London became the first city to host the modern Summer Olympic Games three times.

Along with professional services, media companies are concentrated in London and the media distribu­tion industry is London’s second most competitive sector. UK Life Sciences market had total revenue of £30.7bn in 2015.

Target Audience:  
  • Directors for the Companies
  • Business Delegates
  • Investigators
  • Professors
  • Scientists
  • Research and Diagnostic Laboratories
Major Metabolomics Related Associations in Europe:
  • Association of Applied Biologist
  • British society for Immunology
  • UCL Systems Biology
  • Royal Society of Biology
  • United Kingdom Systems Society

Metabolomics and Systems Biology Related Associations Worldwide:

  • Metabolomics Workbench
  • Metabolomics Society
  • Netherlands Metabolomics centre
  • Cambridge Metabolomics Forum
  • Metabolic Profiling Forum
  • Sciex Metabolomics Community
  • MetaboHUB
  • PhenoMeNal consortium
  • The International Society for Systems Biology (ISSB)
  • ISCB - International Society for Computational Biology
  • Canadian Society for Systems Biology
  • Society for Systems Biology & Translational Research
  • Institute of Molecular Systems Biology
  • Munich Systems Biology Forum
  • Centre for Complex Biological Systems. 
  • Pharmacometabolomics Community (ASCPT)
Major Companies related to Metabolomics:
  • Metabolon, Inc.
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Bruker Corporation
  • Waters Corporation
  • Shimadzu Corporation

Past Conference Report

Metabolomics Congress 2017

The 8th International Conference and Exhibition on Metabolomics & Systems Biology, Metabolomics Congress 2017 was held in Singapore, during May 08 - 10, 2017.

Metabolomics Congress 2017 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas and crux.  

The conference aimed a parallel rail with theme “Rise of New Era in Metabolomics Research”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderators Dr. Paul M. Yen, Duke-NUS Medical School, Singapore and Dr. Scott J. Tebbutt, University of British Columbia & PROOF Centre of Excellence, Canada for their contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Kenneth K. Wu from CMU, NHRI and NTHU, Taiwan; Walter Wahli from Nanyang Technological University, Singapore; Philipp Kaldis from National University of Singapore, Singapore; Scott J. Tebbutt from University of British Columbia & PROOF Centre of Excellence, Canada; Takeshi Kimura from Ajinomoto Co., Inc., Japan; Sean Pin Ng from Singapore Phenome Center, Singapore; Paul M. Yen from Duke-NUS Medical School, Singapore; Maximilian Zucker from numares HEALTH AG, Germany; Jaleel k Ahmed from Babylon University, Iraq; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series LLC offers its heartfelt appreciation to our sponsor “Bruker, Germany”. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

The supporting Sponsor who continuously shows confidence in our conferences was Bruker.

The best poster presentations were awarded by Dr. Björn Riefke Bayer Pharma AG, Germany to:

Fatima AL-Khelaifi, Anti-Doping Lab, Qatar

Conference Series LLC, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conference Series LLC 8th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.


Past Reports  Proceedings  Gallery  

Metabolomics Congress 2016

 

The 5th International Conference and Exhibition on Metabolomics, Metabolomics Congress 2016 was held in Osaka, Japan, during May 16 - 18, 2016.

Metabolomics Congress 2016 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas and crux.  

The conference aimed a parallel rail with theme “Fifty Shades of Metabolomics and Methodological Development”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderators Dr. Eugenia Trushina, Mayo Clinic, USA and Dr. Houkai Li, Shanghai University of Traditional Chinese Medicine, China for their contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Petras Dzeja from Mayo Clinic, USA; Horng-Mo Lee from Taipei Medical University, Taiwan; Eugenia Trushina from Mayo Clinic College of Medicine, USA; Jian Zhi Hu from Pacific Northwest National Laboratory, USA; Loeffler Jean Philippe Université de Strasbourg, France; Björn Riefke from Bayer Pharma AG, Germany; Sam F Y Li, from National University of Singapore, Singapore; Ashkan Emadi from University of Maryland School of Medicine, USA; Houkai Li from Shanghai University of Traditional Chinese Medicine, China; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series LLC offers its heartfelt appreciation to our sponsor “Denator, Sweden”. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

The supporting Sponsor who continuously show confidence in our conferences were Denator.

The best poster presentations were awarded by Dr. Björn Riefke Bayer Pharma AG, Germany to:

Fatin Najwa, Universiti Putra Malaysia, Malaysia

Mei-Chen Lo, Taipei Medical University, Taiwan

Yoriko Heianza, Tulane University, USA
 

Conference Series LLC, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conference Series LLC 5th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.

 


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 11-12, 2018

Speaker Opportunity

Supported By

Journal of Metabolomics: Open Access Journal of Computer Science & Systems Biology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner